# Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: Finn, Olivera, PhD · Condition: Ductal Carcinoma in Situ

- Company: Finn, Olivera, PhD
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06218303

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.